|
SUMO2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.459900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.038000E-01 |
| Normal-vs-Stage2 |
5.838400E-02 |
| Normal-vs-Stage3 |
1.162240E-01 |
| Normal-vs-Stage4 |
2.856000E-02 |
| Stage1-vs-Stage2 |
4.662600E-01 |
| Stage1-vs-Stage3 |
9.664400E-01 |
| Stage1-vs-Stage4 |
7.715900E-02 |
| Stage2-vs-Stage3 |
4.771800E-01 |
| Stage2-vs-Stage4 |
8.864400E-02 |
| Stage3-vs-Stage4 |
7.787900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.930280E-02 |
| Normal-vs-AfricanAmerican |
2.203900E-02 |
| Normal-vs-Asian |
4.332200E-02 |
| Caucasian-vs-AfricanAmerican |
4.998200E-01 |
| Caucasian-vs-Asian |
4.767000E-01 |
| AfricanAmerican-vs-Asian |
6.244200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.204000E-02 |
| Normal-vs-Female |
1.244910E-03 |
| Male-vs-Female |
2.722500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.729880E-02 |
| Normal-vs-Extreme_Weight |
6.906000E-02 |
| Normal-vs-Obese |
2.948300E-02 |
| Normal-vs-Extreme_Obese |
6.339600E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.986600E-01 |
| Normal_Weight-vs-Obese |
4.285000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.818200E-01 |
| Extreme_Weight-vs-Obese |
7.236400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.643400E-01 |
| Obese-vs-Extreme_Obese |
3.280600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.358220E-03 |
| Normal-vs-Age(41-60Yrs) |
1.259640E-03 |
| Normal-vs-Age(61-80Yrs) |
1.800200E-01 |
| Normal-vs-Age(81-100Yrs) |
8.348200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.246000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.337700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.761100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.368390E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.779500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.761800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.095400E-03 |
| Normal-VS-Type2 PRCC |
9.286200E-01 |
| Normal-VS-KIRP CIMP |
3.935000E-03 |
| Normal-VS-Unclassified PRCC |
1.660850E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.161610E-04 |
| Type1 PRCC-VS-KIRP CIMP |
1.673650E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.465580E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.261000E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.397030E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.286100E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.886200E-01 |
| Normal-vs-N1 |
1.139600E-02 |
| Normal-vs-N2 |
1.139570E-02 |
| N0-vs-N1 |
3.344100E-02 |
| N0-vs-N2 |
2.930100E-02 |
| N1-vs-N2 |
6.812000E-01 |
|
|
